This statistic shows the U.S. revenues of Abbott Laboratories from 2006 to 2024. In 2024, Abbott Laboratories generated over 16.3 billion U.S. dollars of revenue in the U.S. market. Abbot Laboratories was a U.S.-based global pharmaceutical and healthcare products company. In January 2013, Abbott was separated into two companies: Abbott Laboratories and AbbVie. Abbott Laboratories specializes in medical products, while AbbVie is responsible for research-based pharmaceuticals.

This statistic shows Abbott's revenues from 2020 to 2024, sorted by country. Abbot was a U.S.-based global pharmaceutical and healthcare products company. In January 2013, Abbott was separated into two companies: Abbott Laboratories and AbbVie. Abbott Laboratories is specialized in medical products, while AbbVie is responsible for research-based pharmaceuticals. In 2024, Abbott Laboratories generated over **** billion U.S. dollars of revenue in the United States.

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

The global revenue in the 'Medical Devices' segment of the medical technology market was forecast to continuously increase between 2024 and 2029 by in total 161.7 billion U.S. dollars (+31.83 percent). After the ninth consecutive increasing year, the revenue is estimated to reach 669.74 billion U.S. dollars and therefore a new peak in 2029. Find further information concerning the revenue in the medical technology market in Argentina and the revenue in the medical technology market in Chile. The Statista Market Insights cover a broad range of additional markets.

The global revenue in the medical technology market was forecast to continuously increase between 2024 and 2029 by in total 175.5 billion U.S. dollars (+29.4 percent). After the ninth consecutive increasing year, the revenue is estimated to reach 772.46 billion U.S. dollars and therefore a new peak in 2029. Find further information concerning the revenue in the medical technology market in China and the revenue in the medical technology market in Peru. The Statista Market Insights cover a broad range of additional markets.

Abbott Labs CEO outlines a $200M tariff impact and the company's response through $500M+ in US manufacturing investments to build resilience, alongside strong quarterly financial results.

Financial overview and grant giving statistics of Abbott Laboratories Employer Credit Union

This statistic shows the net earnings of medical device and pharmaceutical company Abbott from 2006 to 2024. In 2024, Abbott Laboratories reported net earnings of approximately **** billion U.S. dollars, the highest amount in the observed period. In January 2013, Abbott was separated into two companies: Abbott Laboratories and AbbVie. Abbott Laboratories specializes in medical products, while AbbVie is responsible for research-based pharmaceuticals.

Abbot Laboratories is an international medtech and pharmaceutical company headquartered in Chicago, Illinois. In 2013, Abbott Laboratories was split into two companies: Abbot (medical products) and AbbVie (research-based pharmaceuticals). As of 2024, the medical devices segment was the largest segment within the company and generated nearly 19 billion U.S. dollars in revenues. Abbot’s diagnostics segment was, prior to 2023, the largest generator of revenue but dropped to around 9.3 billion U.S. dollars in 2024. Abbott’s company profile Abbott Laboratories was founded in 1888 in Chicago, where the company has remained since. The company operates in around 160 countries globally, covering therapeutic areas such as diabetes, diagnostics, nutrition and cardiovascular disease. The number of employees at Abbot Laboratories (Abbot and AbbVie) has increased over the last several years. The revenues of Abbott declined around the time the company was split in 2013 but has increased significantly recently. Abbott’s global positioning Abbot Laboratories is among the top global health companies based on revenue. Furthermore, AbbVie, Abbott Laboratories’ spin-off company, was ranked second among the top global pharmaceutical companies based on prescription sales.

Abbott and Reckitt see stock drops as a Missouri judge orders a new trial over infant formula liability, overturning a previous verdict.

This statistic shows the total operating cost and expenses of medical technology and pharmaceutical company Abbott from 2014 to 2024. In 2024, Abbott spent a total of approximately 35.1 billion U.S. dollars on operating costs and expenses. In January 2013, Abbott was separated into two companies: Abbott Laboratories and AbbVie. Abbott specializes in medical products, while AbbVie is responsible for research-based pharmaceuticals.

This statistic shows the expenditure of medical device and pharmaceutical company Abbott in research and development from 2004 to 2024. In 2024, Abbott spent approximately **** billion U.S. dollars on R&D. Abbot was a U.S.-based global pharmaceutical and healthcare products company, headquartered in Chicago, Illinois. In January 2013, Abbott was separated into two companies: Abbott Laboratories and AbbVie. Abbott is specialized in medical products, while AbbVie is responsible for research-based pharmaceuticals.

This statistic shows Abbott Laboratories' revenue of the Nutritional segment from 2021 to 2024, broken down by category. In 2024, the International Pediatric Nutritionals segment generated approximately *********** U.S. dollars.

As of 2023, Abbott Laboratories had the largest market share in the IVD market in the United States, at just over ** percent. Following in second place was Danaher with a market share of **** percent.Find more statistics on other topics: a comparison of the value share by brand in Belgium and a comparison of the value share by brand in the United States.The Statista Market Insights cover a broad range of additional markets.

This statistic shows Abbott Laboratories' revenue of the Diagnostics segment from 2020 to 2024, broken down by category. In 2024, the Rapid Diagnostics category within this segment generated nearly three billion U.S. dollars, a significant decrease from the preceding years. The extraordinary growth witnessed in this segment was in large part an increased demand for COVID-19 tests since the beginning of the pandemic.

This statistic shows the results of a survey conducted in the United States in February 2017. U.S. adults were asked if they knew pharmaceutical companies, even if only by name. About 82 percent of survey respondents reported that they knew of Johnson & Johnson, while 46 percent of respondents knew about Abbott Laboratories.

This statistic displays the value of acquisitions made by some of the top pharmaceutical companies between 1994 and 2014. During this time, Abbott Labs spent ***** billion U.S. dollars in acquisitions. Abbott Lab is a United States pharmaceutical and health care products company. In the U.S. industry lobbying group, Pharmaceutical Research and Manufacturers of America, only ** of the original ** members from 1988 still remain as of 2014.

This statistic illustrates the total operating costs and expenses of AbbVie from 2013 to 2024. In 2024, AbbVie had total operating costs and expenses of some 47.2 billion U.S. dollars. Abbot was a U.S.-based global pharmaceutical and healthcare products company, headquartered in Chicago, Illinois. In January 2013, Abbott was separated into two companies: Abbott Laboratories and AbbVie. Abbott Laboratories is now specialized on medical products, while AbbVie is responsible for research-based pharmaceuticals.

This statistic illustrates the basic earnings per share of AbbVie from 2010 to 2024. In 2024, AbbVie's basic earnings per share totaled 2.4 U.S. dollars. Abbot was a U.S.-based global pharmaceutical and healthcare products company, headquartered in Chicago, Illinois. In January 2013, Abbott was separated into two companies: Abbott Laboratories and AbbVie. Abbott Laboratories is now specialized on medical products, while AbbVie is responsible for research-based pharmaceuticals. On May 8, 2020, AbbVie completed the acquisition of Allergan plc.